MOXIFLOXACIN Side Effects

7023657-8 | Convulsion
on Sep 29, 2010 Male patient from UNITED STATES , 69 years of age, weighting 178.6 lb, was treated with Moxifloxacin (View Usage). Patient experienced the following unwanted or unexpected effects: convulsion. Moxifloxacin dosage: 400 Mg Once Iv. Patient was hospitalized.

7021058-X | Extrasystoles
Patient was taking Moxifloxacin (View Usage). Patient had the following side effects: extrasystoles on Sep 07, 2010 from CHINA Additional patient health information: Female patient , 61 years of age, was diagnosed with infection (What is infection?) and. Moxifloxacin dosage: .

7018536-6 | Extrasystoles
Adverse event was reported on Sep 07, 2010 by a Female patient taking Moxifloxacin (View Usage) (Dosage: ) was diagnosed with infection (What is infection?) and. Location: CHINA , 61 years of age, After Moxifloxacin was administered, patient had the following side effects: extrasystoles.

7017885-5 | Ataxia, Dizziness, Tremor
on Sep 27, 2010 Male patient from UNITED STATES , 77 years of age, weighting 206.5 lb, was diagnosed with pneumonia (What is pneumonia?) and was treated with Moxifloxacin (View Usage). Patient experienced the following unwanted or unexpected effects: ataxia (What is ataxia?), dizziness (What is dizziness?), tremor. Moxifloxacin dosage: 400 Mg Every Po. Patient was hospitalized.


7005191-4 | Bursitis, Intervertebral Discitis, Tendonitis
on Sep 14, 2010 Female patient from GERMANY , 70 years of age, was diagnosed with staphylococcal infection (What is staphylococcal infection?) and was treated with Moxifloxacin (View Usage). Patient had the following side effects: bursitis (What is bursitis?), intervertebral discitis, tendonitis. Moxifloxacin dosage: . During the same period patient was treated with CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), CEFUROXIME (View Cefuroxime Review and Cefuroxime Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ), FLUCLOXACILLIN (View Flucloxacillin Review and Flucloxacillin Label ), CLINDAMYCIN (View Clindamycin Review and Clindamycin Label ). Patient was hospitalized.

7005021-0 | Asthenia, Confusional State, Dialysis, Gait Disturbance, Memory Impairment, Motor Dysfunction, Renal Failure Acute, Tubulointerstitial Nephritis
Patient was taking Moxifloxacin (View Usage). After Moxifloxacin was administered, patient had the following side effects: asthenia, confusional state, dialysis (What is dialysis?), gait disturbance, memory impairment, motor dysfunction, renal failure acute, tubulointerstitial nephritis on Sep 20, 2010 from UNITED STATES Additional patient health information: Male patient , 60 years of age, weighting 194.0 lb, was diagnosed with osteomyelitis and. Moxifloxacin dosage: 400 Mg Every Day Po. Patient was hospitalized.

6999955-0 | Grand Mal Convulsion, Status Epilepticus
Adverse event was reported on Sep 14, 2010 by a Female patient taking Moxifloxacin (View Usage) (Dosage: ) was diagnosed with urinary tract infection (What is urinary tract infection?) and. Location: CHINA , 23 years of age, Patient experienced the following unwanted or unexpected effects: grand mal convulsion, status epilepticus. During the same period patient was treated with CEFOPERAZONE SODIUM (View Cefoperazone Sodium Review and Cefoperazone Sodium Label ), SULBACTAM SODIUM (View Sulbactam Sodium Review and Sulbactam Sodium Label ).

6983447-9 | Infusion Related Reaction, Phlebitis, Vasculitis
on Sep 14, 2010 Male patient from UNITED STATES , 63 years of age, weighting 143.3 lb, was treated with Moxifloxacin (View Usage). Patient had the following side effects: infusion related reaction, phlebitis, vasculitis (What is vasculitis?). Moxifloxacin dosage: 400 Mg Once Iv.

6977301-6 | Extrasystoles
on Sep 07, 2010 Female patient from CHINA , 61 years of age, was diagnosed with infection (What is infection?) and was treated with Moxifloxacin (View Usage). After Moxifloxacin was administered, patient had the following side effects: extrasystoles. Moxifloxacin dosage: .

6971950-7 | Electrocardiogram Qt Prolonged
Patient was taking Moxifloxacin (View Usage). Patient experienced the following unwanted or unexpected effects: electrocardiogram qt prolonged on Sep 08, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 128.0 lb, was diagnosed with pneumonia (What is pneumonia?) and. Moxifloxacin dosage: 400mg Iv. During the same period patient was treated with DILTIAZEM (240mg Daily Po) (View Diltiazem Review and Diltiazem Label ).

6965053-5 | Extrasystoles
Adverse event was reported on Aug 26, 2010 by a Female patient taking Moxifloxacin (View Usage) (Dosage: ) was diagnosed with infection (What is infection?) and. Location: CHINA , 61 years of age, Patient had the following side effects: extrasystoles.

6963581-X | Extrasystoles
on Aug 26, 2010 Female patient from CHINA , 61 years of age, was diagnosed with infection (What is infection?) and was treated with Moxifloxacin (View Usage). After Moxifloxacin was administered, patient had the following side effects: extrasystoles. Moxifloxacin dosage: .

6840666-X | Anaphylactic Shock
on Jul 13, 2010 Male patient from UNITED STATES , 60 years of age, was treated with Moxifloxacin (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic shock. Moxifloxacin dosage: Once Iv. Patient was hospitalized.

6760652-8 | Hypotension, Rash, Respiratory Distress, Swelling Face, Vomiting
Patient was taking Moxifloxacin (View Usage). Patient had the following side effects: hypotension, rash (What is rash?), respiratory distress, swelling face, vomiting on Jun 07, 2010 from UNITED STATES Additional patient health information: Male patient , 38 years of age, weighting 205.0 lb, was diagnosed with bronchitis (What is bronchitis?), ear infection (What is ear infection?), pharyngitis, rhinitis and. Moxifloxacin dosage: 400mg Daily Po. Patient was hospitalized.

6760338-X | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Metabolic Acidosis, Renal Failure Acute
Adverse event was reported on Jun 03, 2010 by a Female patient taking Moxifloxacin (View Usage) (Dosage: As Used: 400 Mg) was diagnosed with chronic obstructive pulmonary disease, infection (What is infection?) and. Location: UNITED KINGDOM , 74 years of age, After Moxifloxacin was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, metabolic acidosis, renal failure acute. During the same period patient was treated with CEFUROXIME (View Cefuroxime Review and Cefuroxime Label ), ENOXAPARIN SODIUM (View Enoxaparin Sodium Review and Enoxaparin Sodium Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ).

6752769-9 | Headache, Panic Attack
on Jun 02, 2010 Male patient from UNITED STATES , 59 years of age, weighting 211.0 lb, was diagnosed with bronchitis (What is bronchitis?), infection (What is infection?), otitis media, sinusitis (What is sinusitis?) and was treated with Moxifloxacin (View Usage). Patient experienced the following unwanted or unexpected effects: headache (What is headache?), panic attack. Moxifloxacin dosage: 400 Mg Every Day Po. Patient was hospitalized.

6750397-2 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Bile Duct Stone, Blood Amylase Increased, Lipase Increased, Vanishing Bile Duct Syndrome
on May 17, 2010 Male patient from UNITED STATES , 82 years of age, was treated with Moxifloxacin (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, bile duct stone, blood amylase increased, lipase increased, vanishing bile duct syndrome. Moxifloxacin dosage: 400 Mg Qd Oral.

6748492-7 | Anaphylactic Reaction
Patient was taking Moxifloxacin (View Usage). After Moxifloxacin was administered, patient had the following side effects: anaphylactic reaction on May 27, 2010 from UNITED STATES Additional patient health information: Male patient , 53 years of age, was diagnosed with cellulitis (What is cellulitis?) and. Moxifloxacin dosage: Every Day Po. Patient was hospitalized.

6731407-5 | Oesophageal Disorder, Rash, Swelling
Adverse event was reported on May 18, 2010 by a Male patient taking Moxifloxacin (View Usage) (Dosage: 400 Mg Every Day Po) was diagnosed with chronic obstructive pulmonary disease, respiratory disorder and. Location: UNITED STATES , 59 years of age, weighting 264.4 lb, Patient experienced the following unwanted or unexpected effects: oesophageal disorder, rash (What is rash?), swelling. Patient was hospitalized.

6724791-X | Confusional State, Delirium
on May 13, 2010 Male patient from UNITED STATES , 83 years of age, weighting 168.4 lb, was diagnosed with upper respiratory tract infection and was treated with Moxifloxacin (View Usage). Patient had the following side effects: confusional state, delirium. Moxifloxacin dosage: 400 Mg Every Day Po. Patient was hospitalized.

5211686-6 | Deafness, Tinnitus
on Jan 16, 2007 Female patient from GERMANY , 54 years of age, weighting 163.1 lb, was diagnosed with bronchitis (What is bronchitis?) and was treated with Moxifloxacin (View Usage). After Moxifloxacin was administered, patient had the following side effects: deafness, tinnitus (What is tinnitus?). Moxifloxacin dosage: .

5029082-3 | Arrhythmia
Patient was taking Moxifloxacin (View Usage). Patient experienced the following unwanted or unexpected effects: arrhythmia (What is arrhythmia?) on Jun 06, 2006 from GERMANY Additional patient health information: Female patient , 60 years of age, . Moxifloxacin dosage: .

4828088-4 | Clostridial Infection, Diarrhoea Haemorrhagic
Adverse event was reported on Nov 03, 2005 by a Female patient taking Moxifloxacin (View Usage) (Dosage: 400 Mg, Total Daily, Oral) was diagnosed with bronchitis acute and. Location: UNITED KINGDOM , 61 years of age, Patient had the following side effects: clostridial infection, diarrhoea haemorrhagic. During the same period patient was treated with SERETIDE MITE (View Seretide Mite Review and Seretide Mite Label ), THEOPHYLLINE (View Theophylline Review and Theophylline Label ), CETIRIZINE HCL (View Cetirizine Hcl Review and Cetirizine Hcl Label ), COMBIVENT (View Combivent Review and Combivent Label ). Patient was hospitalized.

4818633-7 | Hypersensitivity
on Oct 27, 2005 Female patient from BELGIUM , 35 years of age, weighting 149.9 lb, was diagnosed with pneumonia (What is pneumonia?) and was treated with Moxifloxacin (View Usage). After Moxifloxacin was administered, patient had the following side effects: hypersensitivity. Moxifloxacin dosage: 400 Mg, Total Dialy, Intravenous. During the same period patient was treated with AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ).

4814355-7 | Electrocardiogram Qt Corrected Interval Prolonged
on Oct 27, 2005 Male patient from UNITED STATES , 69 years of age, weighting 177.0 lb, was diagnosed with pneumonia (What is pneumonia?) and was treated with Moxifloxacin (View Usage). Patient experienced the following unwanted or unexpected effects: electrocardiogram qt corrected interval prolonged. Moxifloxacin dosage: 400mg Daily Iv Once. During the same period patient was treated with SODIUM NITROPRUSSIDE (View Sodium Nitroprusside Review and Sodium Nitroprusside Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ).

4749183-4 | Abdominal Pain, Aortic Aneurysm, Arrhythmia, Artery Dissection, Feeling Hot, Hypersensitivity, Hypoperfusion, Pain In Extremity, Pulmonary Embolism
Patient was taking Moxifloxacin (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), aortic aneurysm (What is aortic aneurysm?), arrhythmia (What is arrhythmia?), artery dissection, feeling hot, hypersensitivity, hypoperfusion, pain in extremity, pulmonary embolism (What is pulmonary embolism?) on Aug 12, 2005 from SOUTH AFRICA Additional patient health information: Male patient , 38 years of age, weighting 101.9 lb, was diagnosed with pulmonary tuberculosis and. Moxifloxacin dosage: Qd, Oral. During the same period patient was treated with ISONIAZID (800 Mg, Qd, Oral) (View Isoniazid Review and Isoniazid Label ), RIFAMPIN (600 Mg, Qd, Oral) (View Rifampin Review and Rifampin Label ), PYRAZINAMIDE (1500 Mg, Qd, Oral) (View Pyrazinamide Review and Pyrazinamide Label ), B6 (View B6 Review and B6 Label ).

4748407-7 | Anorexia, Clostridium Colitis, Diarrhoea, Dyspnoea, Haematocrit Decreased, Haemoglobin Decreased, Platelet Count Increased, Pyrexia
Adverse event was reported on Aug 12, 2005 by a Male patient taking Moxifloxacin (View Usage) (Dosage: Oral) . Location: UNITED STATES , 46 years of age, After Moxifloxacin was administered, patient had the following side effects: anorexia, clostridium colitis, diarrhoea, dyspnoea, haematocrit decreased, haemoglobin decreased, platelet count increased, pyrexia. During the same period patient was treated with ISONIAZID (View Isoniazid Review and Isoniazid Label ), RIFAMPIN (View Rifampin Review and Rifampin Label ), PYRAZINAMIDE (View Pyrazinamide Review and Pyrazinamide Label ). Patient was hospitalized.

4746776-5 | Adrenocortical Insufficiency Acute, Alcohol Withdrawal Syndrome, Arthropod Bite, Circulatory Collapse, Disseminated Intravascular Coagulation, Eosinophilia, Hypersensitivity, Hypotension, Inflammation
on Aug 05, 2005 Female patient from SWITZERLAND , 61 years of age, was treated with Moxifloxacin (View Usage). Patient experienced the following unwanted or unexpected effects: adrenocortical insufficiency acute, alcohol withdrawal syndrome, arthropod bite, circulatory collapse, disseminated intravascular coagulation, eosinophilia, hypersensitivity, hypotension, inflammation. Moxifloxacin dosage: 400 Mg, Qd, Oral. During the same period patient was treated with BECLOMETHASONE DIPROPIONATE (Respiratory Inhalation) (View Beclomethasone Dipropionate Review and Beclomethasone Dipropionate Label ), FORMOTEROL (View Formoterol Review and Formoterol Label ), COLECALCIFEROL (View Colecalciferol Review and Colecalciferol Label ), DIPROPHOS (View Diprophos Review and Diprophos Label ), CELESTON (View Celeston Review and Celeston Label ), DIPIPERONE (View Dipiperone Review and Dipiperone Label ), LEPONEX (View Leponex Review and Leponex Label ). Patient was hospitalized.

4738053-3 | Abdominal Pain, Clostridial Infection, Diarrhoea, Nausea
on Aug 05, 2005 Male patient from UNITED STATES , 45 years of age, was diagnosed with infection (What is infection?), pneumonia (What is pneumonia?) and was treated with Moxifloxacin (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), clostridial infection, diarrhoea, nausea (What is nausea?). Moxifloxacin dosage: 400 Mg Po Qd X 10 Days. Patient was hospitalized.

4727499-5 | Blood Pressure Systolic Increased, Cough, Crepitations, Dyspnoea, Electrocardiogram Qt Prolonged, Electrocardiogram St Segment Depression, Hypoxia, Oedema Peripheral, Pharyngolaryngeal Pain
Patient was taking Moxifloxacin (View Usage). After Moxifloxacin was administered, patient had the following side effects: blood pressure systolic increased, cough, crepitations, dyspnoea, electrocardiogram qt prolonged, electrocardiogram st segment depression, hypoxia, oedema peripheral, pharyngolaryngeal pain on Jul 27, 2005 from UNITED STATES Additional patient health information: Male patient , 80 years of age, weighting 172.0 lb, was diagnosed with pneumonia (What is pneumonia?) and. Moxifloxacin dosage: 400mg Only Given 1 Dose (once).

4691869-4 | Bacteraemia, Colitis, Lactic Acidosis, Septic Shock
Adverse event was reported on Jun 15, 2005 by a Male patient taking Moxifloxacin (View Usage) (Dosage: 400 Mg Po Daily) was diagnosed with pneumonia (What is pneumonia?) and. Location: , 75 years of age, weighting 147.7 lb, Patient experienced the following unwanted or unexpected effects: bacteraemia, colitis, lactic acidosis, septic shock. During the same period patient was treated with ADVAIR (View Advair Review and Advair Label ), SPIRIVA (View Spiriva Review and Spiriva Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ). Patient was hospitalized.

4688444-4 | Empyema
on Jun 02, 2005 Female patient from , 38 years of age, weighting 176.4 lb, was diagnosed with pneumonia (What is pneumonia?) and was treated with Moxifloxacin (View Usage). Patient had the following side effects: empyema. Moxifloxacin dosage: 400 Mg, Qd, Oral. During the same period patient was treated with TEOBAG (View Teobag Review and Teobag Label ), COMBIVENT (View Combivent Review and Combivent Label ), VENTOLIN (View Ventolin Review and Ventolin Label ), APROL (View Aprol Review and Aprol Label ), NOVALGIN/SWE/ (View Novalgin/swe/ Review and Novalgin/swe/ Label ), SETAMOL (View Setamol Review and Setamol Label ), ASIST (View Asist Review and Asist Label ), LASIX (View Lasix Review and Lasix Label ). Patient was hospitalized.

4687236-X | Diarrhoea, Urinary Hesitation
on May 31, 2005 Male patient from , 65 years of age, was diagnosed with lower respiratory tract infection and was treated with Moxifloxacin (View Usage). After Moxifloxacin was administered, patient had the following side effects: diarrhoea, urinary hesitation. Moxifloxacin dosage: Oral. During the same period patient was treated with AMITRIPTYLINE (View Amitriptyline Review and Amitriptyline Label ), TOLBUTAMIDE (View Tolbutamide Review and Tolbutamide Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), FRUSEMIDE (View Frusemide Review and Frusemide Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), CO CODAMOL (View Co-codamol Review and Co-codamol Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ).

4577528-7 | Condition Aggravated, Coronary Artery Disease, International Normalised Ratio Increased, Pneumonia
Patient was taking Moxifloxacin (View Usage). Patient experienced the following unwanted or unexpected effects: condition aggravated, coronary artery disease (What is coronary artery disease?), international normalised ratio increased, pneumonia (What is pneumonia?) on Jan 27, 2005 from Additional patient health information: Male patient , 63 years of age, was diagnosed with pneumonia (What is pneumonia?), atrial fibrillation (What is atrial fibrillation?) and. Moxifloxacin dosage: 400 Mg, Total Daily, Oral. During the same period patient was treated with WARFARIN SODIUM (See Image) (View Warfarin Sodium Review and Warfarin Sodium Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), VALSARTAN (View Valsartan Review and Valsartan Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ).

4569579-3 | Bronchitis Chronic, Chronic Obstructive Pulmonary Disease, Haematemesis, Haemoglobin Decreased, International Normalised Ratio Increased, Pneumonia Bacterial, Upper Gastrointestinal Haemorrhage
Adverse event was reported on Jan 27, 2005 by a Male patient taking Moxifloxacin (View Usage) (Dosage: 400 Mg Total Daily Oral) . Location: , 83 years of age, Patient had the following side effects: bronchitis chronic, chronic obstructive pulmonary disease, haematemesis, haemoglobin decreased, international normalised ratio increased, pneumonia bacterial, upper gastrointestinal haemorrhage. During the same period patient was treated with WARFARIN SODIUM (4 Mg Total Daily) (View Warfarin Sodium Review and Warfarin Sodium Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), THEOPHYLLINE (View Theophylline Review and Theophylline Label ), VERAPAMIL (View Verapamil Review and Verapamil Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), IPATROPIUM BROMIDE (View Ipatropium Bromide Review and Ipatropium Bromide Label ), FLUTICASONE PROPIONATE (View Fluticasone Propionate Review and Fluticasone Propionate Label ), OXAZEPAM (View Oxazepam Review and Oxazepam Label ).

4563641-7 | Haemoglobin Decreased, International Normalised Ratio Increased
on Jan 11, 2005 Male patient from , 92 years of age, was diagnosed with pneumonia (What is pneumonia?), atrial fibrillation (What is atrial fibrillation?) and was treated with Moxifloxacin (View Usage). After Moxifloxacin was administered, patient had the following side effects: haemoglobin decreased, international normalised ratio increased. Moxifloxacin dosage: 400 Mg, Total Daily, Oral. During the same period patient was treated with WARFARIN SODIUM (3 Mg, Total Daily) (View Warfarin Sodium Review and Warfarin Sodium Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), CEFUROXIME (View Cefuroxime Review and Cefuroxime Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), CLINDAMYCIN (View Clindamycin Review and Clindamycin Label ), CITALOPRAM (View Citalopram Review and Citalopram Label ).

4562905-0 | Cardiac Failure Congestive, International Normalised Ratio Increased
on Jan 11, 2005 Female patient from , 73 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Moxifloxacin (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure congestive, international normalised ratio increased. Moxifloxacin dosage: 400 Mg, Total Daily, Oral. During the same period patient was treated with WARFARIN SODIUM (2.5 Mg, Total Daily, Unk) (View Warfarin Sodium Review and Warfarin Sodium Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), PROCHLORPERAZINE (View Prochlorperazine Review and Prochlorperazine Label ), CITALOPRAM (View Citalopram Review and Citalopram Label ), ATENOLOL (View Atenolol Review and Atenolol Label ).

4562901-3 | International Normalised Ratio Increased
Patient was taking Moxifloxacin (View Usage). Patient had the following side effects: international normalised ratio increased on Jan 11, 2005 from Additional patient health information: Male patient , 75 years of age, was diagnosed with bronchitis chronic, condition aggravated, pneumonia bacterial, atrial fibrillation (What is atrial fibrillation?) and. Moxifloxacin dosage: 400 Mg, Total Daily, Oral. During the same period patient was treated with WARFARIN SODIUM (2.5 Mg, Total Daily) (View Warfarin Sodium Review and Warfarin Sodium Label ), SOTALOL HCL (View Sotalol Hcl Review and Sotalol Hcl Label ), BUDESONIDE (View Budesonide Review and Budesonide Label ), METHYLPREDNISOLONE (View Methylprednisolone Review and Methylprednisolone Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), IPATROPIUM BROMIDE (View Ipatropium Bromide Review and Ipatropium Bromide Label ).

4562887-1 | International Normalised Ratio Increased, Overdose
Adverse event was reported on Jan 11, 2005 by a Male patient taking Moxifloxacin (View Usage) (Dosage: 400 Mg, Total Daily, Oral) was diagnosed with pneumonia (What is pneumonia?), atrial fibrillation (What is atrial fibrillation?) and. Location: , 63 years of age, After Moxifloxacin was administered, patient had the following side effects: international normalised ratio increased, overdose. During the same period patient was treated with WARFARIN SODIUM (See Image) (View Warfarin Sodium Review and Warfarin Sodium Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), VALSARTAN (View Valsartan Review and Valsartan Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ).

4557160-1 | Chronic Obstructive Pulmonary Disease, Haemoglobin Decreased, International Normalised Ratio Increased, Upper Gastrointestinal Haemorrhage
on Jan 11, 2005 Male patient from , 83 years of age, was diagnosed with bronchitis chronic, pneumonia bacterial, atrial fibrillation (What is atrial fibrillation?) and was treated with Moxifloxacin (View Usage). Patient experienced the following unwanted or unexpected effects: chronic obstructive pulmonary disease, haemoglobin decreased, international normalised ratio increased, upper gastrointestinal haemorrhage. Moxifloxacin dosage: 400 Mg, Total Daily, Oral. During the same period patient was treated with WARFARIN SODIUM (4 Mg, Total Daily) (View Warfarin Sodium Review and Warfarin Sodium Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), THEOPHYLLINE (View Theophylline Review and Theophylline Label ), VERAPAMIL (View Verapamil Review and Verapamil Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), IPATROPIUM BROMIDE (View Ipatropium Bromide Review and Ipatropium Bromide Label ), FLUTICASONE PROPIONATE (View Fluticasone Propionate Review and Fluticasone Propionate Label ).

4556991-1 | International Normalised Ratio Increased
on Jan 11, 2005 Female patient from , 73 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and was treated with Moxifloxacin (View Usage). Patient had the following side effects: international normalised ratio increased. Moxifloxacin dosage: 400 Mg, Total Daily, Oral. During the same period patient was treated with WARFARIN SODIUM (2.5 Mg , Total Daily) (View Warfarin Sodium Review and Warfarin Sodium Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), CLONAZEPAM (View Clonazepam Review and Clonazepam Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), PROCHLORPERAZINE (View Prochlorperazine Review and Prochlorperazine Label ), CITALOPRAM (View Citalopram Review and Citalopram Label ), ATENOLOL (View Atenolol Review and Atenolol Label ).